In this analysis, the CCNA1, CDKN1C, FOS, JUN, and SFN genes exhibited a significant difference (p < 0.05), with reduced gene expression observed in the FTC group (Analysis 5). The gene discussed is FOS; the disease is thyroid cancer, nonmedullary, 2.